potential crypto 2021 Reviews

General Motors (GM): The unmanned business Cruise and GM Technical team will be merged, and the plan is expected to be completed in the first half of 2025. According to the priority of GM's capital allocation, GM will no longer fund Cruise's self-driving taxi development business.The latest monitoring report released by the World Bank shows that Lebanon's GDP will drop by 6.6% in 2024. The latest Lebanon economic monitoring report released by the World Bank on the 10th shows that the real GDP of Lebanon will drop by 6.6% in 2024 due to the influence of lebanon war. According to the report, the large-scale displacement, destruction and the reduction of personal consumption caused by the conflict have had a devastating impact on Lebanon's economy and exacerbated the country's macroeconomic challenges. The report emphasizes that after the upgrading of lebanon war in September this year, Lebanese key industries, including tourism, have been seriously affected.The chief operating officer of BlackRock seeks to improve its technical and artificial intelligence capabilities. The chief operating officer of BlackRock, the world's largest asset management company, said on Tuesday that the company is looking for opportunities to expand its technical capabilities, including in the field of artificial intelligence. Rob Goldstein, chief operating officer of BlackRock, said in an interview at a conference in new york: "There are always some capabilities that can be improved."

Shengmei Shanghai: The plasma enhanced atomic layer deposition furnace tube equipment has passed the preliminary verification. Shengmei Semiconductor Equipment (Shanghai) Co., Ltd. announced in Guanwei today that its Ultra Fn A plasma enhanced atomic layer deposition furnace tube equipment (PEALD) launched in 2024 has passed the preliminary process verification of a semiconductor customer in Chinese mainland, and is undergoing the final optimization and preparing for mass production. Shengmei Shanghai also announced that its Ultra Fn A Thermal Atomic Layer Deposition Furnace Equipment (Thermal ALD) launched in 2022 has also successfully passed the process verification of another leading Chinese mainland customer, and its performance parameters are comparable to or even better than those of similar international competitors.GM will withdraw from the driverless taxi business, and the Cruise self-driving car division of GM will withdraw from the driverless taxi business. According to a statement on Tuesday, Cruise and GM's technical team will be combined to focus on developing autonomous driving and advanced driver safety technology for GM's future sales models. GM said that it will no longer provide funds for the development of self-driving taxis "considering the large amount of time and resources needed to expand its business scale and the increasingly fierce competition in the self-driving taxi market". The company said that giving up the development of self-driving taxis will save it more than $1 billion in annual costs.Shengmei Shanghai: The plasma enhanced atomic layer deposition furnace tube equipment has passed the preliminary verification. Shengmei Semiconductor Equipment (Shanghai) Co., Ltd. announced in Guanwei today that its Ultra Fn A plasma enhanced atomic layer deposition furnace tube equipment (PEALD) launched in 2024 has passed the preliminary process verification of a semiconductor customer in Chinese mainland, and is undergoing the final optimization and preparing for mass production. Shengmei Shanghai also announced that its Ultra Fn A Thermal Atomic Layer Deposition Furnace Equipment (Thermal ALD) launched in 2022 has also successfully passed the process verification of another leading Chinese mainland customer, and its performance parameters are comparable to or even better than those of similar international competitors.

Google asked the US Federal Trade Commission (FTC) to terminate the exclusive cloud service agreement between Microsoft and OpenAI.Maotai Group went to Laos, Cambodia and Thailand for investigation and exchange. From December 3 to 9, local time, Wan Bo, member of the Party Committee and deputy general manager of Maotai Group, led a team to Laos, Cambodia and Thailand for investigation and exchange. Through in-depth investigation of the local market, the brand promotion activities of "Maotai Night" were carried out, which continued to promote Maotai's deep cultivation in Southeast Asia. During this period, Wanbo and his party also visited Eisenwo, Chairman of the China-Cambodia Friendship Exchange Association, Princess Norodom Allen Rasmi, Director of the Cambodian Royal Modita Foundation, former Thai Deputy Prime Minister Chichai Vanashati, Chairman of the Thailand-China Friendship Association and former Thai Deputy Prime Minister Gong Taparansi, and Lao Minister of Education and Sports Pu Simarong to discuss how Maotai culture and Southeast Asian cultures can be blended and promoted together to help Maotai and China traditional culture go to sea.Guotai Junan's annual strategy for innovative drugs in 2025: innovative pharmaceutical companies have accelerated into the harvest period, and the valuation has been at a historical low in the past five years. Guotai Junan said that the centralized purchasing policy has become stable, mature and normalized, and the marginal impact has weakened. Innovative drugs have gained policy inclination in the medical insurance negotiation. In the past two years, the policy has continued to promote pharmaceutical innovation, and the top-level design and local supporting chain support the development of innovative drugs. Commercial insurance is expected to bring new growth momentum to China's pharmaceutical market, and the overall industry trend is upward. At present, the trend of innovative drug industry is improving, the supply continues to accelerate, and a number of domestic innovative drugs are approved soon, which is expected to drive a new round of heavy volume. At the same time, the commercialization has achieved remarkable results and has occupied a dominant position in some sub-sectors. Pharma's performance continued to differentiate, and innovative drugs and just-needed drugs performed well. Biotech commercialization continues to increase, per capita yield continues to increase, the node of turning losses is approaching, and innovation ushers in the harvest period. Horizontal comparison: compared with overseas peers, the overall valuation of domestic innovative pharmaceutical companies is in a historically low range; Vertical comparison: the valuation of SW- pharmaceutical biology and SW- chemical preparations is at a historical low in the past five years, and it is expected that the valuation of subsequent sectors will pick up.